Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 History of Cancer, Ancient and Modern Treatment Methods.

Literature DB >> 20740081

History of Cancer, Ancient and Modern Treatment Methods.

Akulapalli Sudhakar¹.

Abstract

Entities: Disease

Year: 2009 PMID： 20740081 DOI： 10.4172/1948-5956.100000e2

Source DB: PubMed Journal: J Cancer Sci Ther

× No keyword cloud information.

7 in total

1. Cancer: an historical perspective.

Authors: G T Diamandopoulos
Journal: Anticancer Res Date: 1996 Jul-Aug Impact factor: 2.480

2. Early contributions to the surgery of cancer: William S. Halsted, Hugh H. Young and John G. Clark.

Authors: A M Harvey
Journal: Johns Hopkins Med J Date: 1974-12

3. A conceptual history of cancer.

Authors: C G Kardinal; J W Yarbro
Journal: Semin Oncol Date: 1979-12 Impact factor: 4.929

4. Selected concepts of cancer as a disease: from the Greeks to 1900.

Authors: B B Gallucci
Journal: Oncol Nurs Forum Date: 1985 Jul-Aug Impact factor: 2.172

Review 5. Basement membranes: structure, assembly and role in tumour angiogenesis.

Authors: Raghu Kalluri
Journal: Nat Rev Cancer Date: 2003-06 Impact factor: 60.716

6. Signaling mechanisms of endogenous angiogenesis inhibitors derived from type IV collagen.

Authors: Akulapalli Sudhakar; Chandra S Boosani
Journal: Gene Regul Syst Bio Date: 2007-10-14

Review 7. Inhibition of tumor angiogenesis by tumstatin: insights into signaling mechanisms and implications in cancer regression.

Authors: Akulapalli Sudhakar; Chandra S Boosani
Journal: Pharm Res Date: 2008-06-13 Impact factor: 4.200

7 in total

58 in total

1. The Impact of a Radiation Oncologist led Oncology Curriculum on Medical Student Knowledge.

Authors: Ankit Agarwal; Aishwarya Shah; Bhartesh Shah; Brian Koottappillil; Ariel E Hirsch
Journal: J Cancer Educ Date: 2018-12 Impact factor: 2.037

2. Copy Number Alterations in Tumor Genomes Deleting Antineoplastic Drug Targets Partially Compensated by Complementary Amplifications.

Authors: Ha Vu Tran; Alexandra K Kiemer; Volkhard Helms
Journal: Cancer Genomics Proteomics Date: 2018 Sep-Oct Impact factor: 4.069

Review 3. Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.

Authors: Omid Zarei; Silvia Benvenuti; Fulya Ustun-Alkan; Maryam Hamzeh-Mivehroud; Siavoush Dastmalchi
Journal: J Cancer Res Clin Oncol Date: 2016-08-08 Impact factor: 4.553

4. Combination Cancer Therapy Using Chimeric Antigen Receptor-Engineered Natural Killer Cells as Drug Carriers.

Authors: Elizabeth L Siegler; Yu Jeong Kim; Xianhui Chen; Natnaree Siriwon; John Mac; Jennifer A Rohrs; Paul D Bryson; Pin Wang
Journal: Mol Ther Date: 2017-08-19 Impact factor: 11.454

5. Investigation of solid tumor progression with account of proliferation/migration dichotomy via Darwinian mathematical model.

Authors: Maxim Kuznetsov; Andrey Kolobov
Journal: J Math Biol Date: 2019-10-01 Impact factor: 2.259

Review 6. Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain.

Authors: Liron L Israel; Anna Galstyan; Eggehard Holler; Julia Y Ljubimova
Journal: J Control Release Date: 2020-01-07 Impact factor: 9.776

7. Extremely low frequency electromagnetic field sensitizes cisplatin-resistant human ovarian adenocarcinoma cells via P53 activation.

Authors: Javad Baharara; Nasrin Hosseini; Tayebe Ramezani Farzin
Journal: Cytotechnology Date: 2015-09-14 Impact factor: 2.058